Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
Apply
RO7771950 & Tucatinib
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step